"US Close to Funding Moderna's mRNA Bird Flu Vaccine Trial"
TL;DR Summary
The U.S. government is close to finalizing a deal to fund a late-stage trial of Moderna's mRNA bird flu vaccine, mRNA-1018, as the outbreak spreads in dairy cows. The Biomedical Advanced Research and Development Authority (BARDA) may provide funding and commit to purchasing doses if trials are successful. Moderna has completed dosing in an early-to-mid stage study and expects data soon. The U.S. is also in discussions with Pfizer and has a stockpile of bird flu vaccines and antivirals.
- US nears deal to fund Moderna's bird flu vaccine trial, FT reports Reuters
- U.S. Nears Deal To Fund Moderna mRNA Bird Flu Shot Trial, Report Says Forbes
- Scientists concerned over eggs for bird flu vaccine CBS News
- Moderna's stock climbs on report that bird-flu vaccine funding is near MarketWatch
- mRNA vaccine by UPenn scientists could manage bird flu outbreak The Hill
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
1 min
vs 2 min read
Condensed
78%
359 → 79 words
Want the full story? Read the original article
Read on Reuters